Tilrekimig2

A4DAB265 | Phase-II
TSLP
G1 / None
Pfizer
Phase-II
Trispecific Mixed mAbs; Monospecific entry
PF-07275315 PF 07275315 PF07275315
—
IMGT PubChem (507427835) PubChem (520378100) Thera-SAbDab YAbS
Avg A4D Score
-0.7077
Score Range
-0.71
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB265_5j13_C_B 5j13 97% -0.7077 6.5 4.0 -0.6069 -0.7216